Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics

Lancet

Volumn 349, Issue 9067, 1997, Pages 1735-1739

  Sabri, Osama ^a   Erkwoh, Ralf ^a   Schreckenberger, Mathias ^a   Owega, Ammar ^a   Sass, Henning ^a   Buell, Udalrich ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN PERFUSION; BRAIN TOMOGRAPHY; CINGULATE GYRUS; CLINICAL ARTICLE; DELUSION; FEMALE; FRONTAL CORTEX; HALLUCINATION; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TEMPORAL CORTEX;

EID: 0030917261     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)08380-8     Document Type: Article

References (27)

1. Brodie JD, Christman DR, Corona JF, et al. Patterns of metabolic activity in the treatment of schizophrenia. Ann Neurol 1984; 15: 166-69.
2. Lewis SW, Ford RA, Syed GM, Reveley AM, Toone BU. A controlled study of Tc-99m-HMPAO single-photon emission imaging in chronic schizophrenia. Psychol Med 1992; 22: 27-35.
3. Wolkin A, Jaeger J, Brodie JD, et al. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. Am J Psychiatry 1985; 142: 564-71.
4. Catafau AM, Parellada E, Lomeña FJ, et al. Prefrontal and temporal blood flow in schizophrenia. J Nucl Med 1994; 35: 935-41.
5. Szechtman H, Nahmias C, Garnett ES, et al. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry 1988; 45: 523-32.
6. Volkow ND, Brodie JD, Wolf AP, Angrist B, Russel J, Cancro R. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. J Neurol Neurosurg Psychiatry 1986; 49: 1199-202.
7. Wiesel FA, Wik G, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatr Scand 1987; 76: 628-41.
8. 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet 1983; ii: 1448-52.
9. Paulman RG, Devous MD Sr, Gregory RR, et al. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol Psychiatry 1990; 27: 377-99.
10. American Psychiatric Association. DSM-III-R: diagnostic and statistical manual of mental disorders, 3rd edn. Washington DC: American Psychiatric Press, 1987.
11. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76.
12. Kaiser HJ, Sabri O, Wagenknecht G, Lege B, Hellwig D, Büll U. A method of correlating and merging cerebral morphology and function by a special headholder. Nuklearmedizin 1994; 33: 123-26.
13. Sabri O, Hellwig D, Kaiser HJ, et al. Effects of morphological changes on perfusion and metabolism in cerebral microangiopathy. Nuklearmedizin 1995; 34: 50-56.
14. Costa DC, Ell PJ, Cullum ID, et al. The in vivo distribution of 99mT c-HMPAO in normal man. Nucl Med Commun 1986; 7: 647-58.
15. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25: 638-43.
16. Syed GMS, Barrett JJ, Toone BK. What does rCBF SPECT offer in schizophrenia? Nucl Med Commun 1992; 13: 879-84.
17. Syed GMS, Eagger S, Toone BK, et al. Quantification of regional cerebral blood flow (rCBF) using 99T c-m-HMPAO and SPECT: choice of the reference region. Nucl Med Commun 1992; 13: 811-16.
18. Talairach J, Szlika G. Atlas d'anatomie stéréotaxique du télencéphale. Paris: Masson, 1967.
19. Kretschmann HJ, Weinrich W. Klinische Neuroanatomie und kranielle Bilddiagnostik, 2nd edn. Stuttgart:Thieme, 1991.
20. Kojima A, Matsumoto M, Takahashi M, et al. Effect of spatial resolution on SPECT quantification values. J Nucl Med 1989; 30: 508-14.
21. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
22. Flury B, Riedwyl H. Faktorenanalyse. In: Angewandte multivariate Statistik. Stuttgart: Fischer, 1983: 135-49.
23. Ebmeier KP, Blackwood DHR, Murray C, et al. Single-photon emission computed tomography with 99mT c-exametazime in unmedicated schizophrenic patients. Biol Psychiatry 1993; 33: 487-95.
24. Andreasen NC, Rezai K, Allger R, et al. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Arch Gen Psychiatry 1992; 49: 943-58.
25. Wolkin A, Sanfilipo M, Wolf AP, et al. Negative symptoms and hypofrontality in chronic schizophrenia. Arch Gen Psychiatry 1992; 49: 959-65.
26. Liddle PF, Friston KJ, Frith CD, et al. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992; 160: 179-86.
27. Mellers JDC, Sham P, Jones PB, Toone BK, Murray RM. A factor analytic study of symptoms in acute schizophrenia. Acta Psychiatr Scand 1996; 93: 92-98.